Duke University: Carcinoma, Renal Cell trials

The registry lists 15 Carcinoma, Renal Cell studies with Duke University as lead sponsor. 0 are open to participants now and 3 have results posted.

Early Phase 1 1Phase 1 2Phase 2 3No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise TestingCompletedNCT03109015Phase 2Results posted
• Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaCompletedNCT01108445Phase 2Results posted
• Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)TerminatedNCT00672178Phase 1/2Results posted
• Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)WithdrawnNCT06603155Not applicable
• Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell CarcinomaActive, not recruitingNCT04919122
• Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
• Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal CancerTerminatedNCT03867045Not applicable
• INTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell CarcinomaTerminatedNCT03692338Not applicable
• INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological CancersCompletedNCT03071328Early Phase 1
• Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)Active, not recruitingNCT02978118
• NCCN Renal Cell RegistryCompletedNCT02677337Not applicable
• Interleukin-2-Induced Cognitive/Affective/Sleep SymptomsCompletedNCT02150369
• Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)CompletedNCT02080650Not applicable
• RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)TerminatedNCT02026960Not applicable
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney CancerCompletedNCT00005816Phase 1